Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 132

1.

Enhancing Access to Psychiatric Care for Posttraumatic Stress Disorder in Veterans with Mild Traumatic Brain Injury through Integrated Services.

Baig MR, Tapia RN, Meraj A, Pugh JA, Roache JD, Finley EP.

Psychiatr Q. 2019 Aug 24. doi: 10.1007/s11126-019-09668-7. [Epub ahead of print]

PMID:
31446544
2.

Mediation of suicide ideation in prolonged exposure therapy for posttraumatic stress disorder.

Brown LA, Zang Y, Benhamou K, Taylor DJ, Bryan CJ, Yarvis JS, Dondanville KA, Litz BT, Mintz J, Roache JD, Pruiksma KE, Fina BA, Young-McCaughan S, Peterson AL, Foa EB; STRONG STAR Consortium.

Behav Res Ther. 2019 Aug;119:103409. doi: 10.1016/j.brat.2019.103409. Epub 2019 May 23.

PMID:
31176888
3.

Salience Network Disruption in U.S. Army Soldiers With Posttraumatic Stress Disorder.

Abdallah CG, Averill CL, Ramage AE, Averill LA, Goktas S, Nemati S, Krystal JH, Roache JD, Resick PA, Young-McCaughan S, Peterson AL, Fox P; STRONG STAR Consortium.

Chronic Stress (Thousand Oaks). 2019 Jan-Dec;3. doi: 10.1177/2470547019850467. Epub 2019 May 15.

4.

Enhancing Completion of Cognitive Processing Therapy for Posttraumatic Stress Disorder with Quetiapine in Veterans with Mild Traumatic Brain Injury: a Case Series.

Baig MR, Wilson JL, Lemmer JA, Beck RD, Peterson AL, Roache JD.

Psychiatr Q. 2019 Jun;90(2):431-445. doi: 10.1007/s11126-019-09638-z.

PMID:
31054021
5.

Does prolonged exposure increase suicide risk? Results from an active duty military sample.

Brown LA, McLean CP, Zang Y, Zandberg L, Mintz J, Yarvis JS, Litz BT, Peterson AL, Bryan CJ, Fina B, Petersen J, Dondanville KA, Roache JD, Young-McCaughan S, Foa EB; STRONG STAR consortium.

Behav Res Ther. 2019 Jul;118:87-93. doi: 10.1016/j.brat.2019.04.003. Epub 2019 Apr 10.

PMID:
31022593
6.

Reduced Salience and Enhanced Central Executive Connectivity Following PTSD Treatment.

Abdallah CG, Averill CL, Ramage AE, Averill LA, Alkin E, Nemati S, Krystal JH, Roache JD, Resick P, Young-McCaughan S, Peterson AL, Fox P; STRONG STAR Consortium.

Chronic Stress (Thousand Oaks). 2019 Jan-Feb;3. doi: 10.1177/2470547019838971. Epub 2019 Apr 15.

7.

Repeated ketamine infusions for antidepressant-resistant PTSD: Methods of a multicenter, randomized, placebo-controlled clinical trial.

Abdallah CG, Roache JD, Averill LA, Young-McCaughan S, Martini B, Gueorguieva R, Amoroso T, Southwick SM, Guthmiller K, López-Roca AL, Lautenschlager K, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH; Consortium to Alleviate PTSD.

Contemp Clin Trials. 2019 Jun;81:11-18. doi: 10.1016/j.cct.2019.04.009. Epub 2019 Apr 15.

PMID:
30999057
8.

Examination of Treatment Effects on Hazardous Drinking Among Service Members With Posttraumatic Stress Disorder.

Dondanville KA, Wachen JS, Hale WJ, Mintz J, Roache JD, Carson C, Litz BT, Yarvis JS, Young-McCaughan S, Peterson AL, Resick PA; STRONG STAR Consortium.

J Trauma Stress. 2019 Apr;32(2):310-316. doi: 10.1002/jts.22393. Epub 2019 Mar 28.

PMID:
30920684
9.

Estimating resource utilization demands in implementing statewide screening, brief intervention, and referral to treatment for alcohol-impaired drivers.

Mathias CW, Moon TJ, Karns-Wright TE, Hill-Kapturczak N, Roache JD, Mullen J, Dougherty DM.

Traffic Inj Prev. 2019;20(1):15-22. doi: 10.1080/15389588.2018.1528500. Epub 2019 Feb 4.

PMID:
30715916
10.

Factor Structure and Psychometric Properties of the Peritraumatic and Posttraumatic Emotions Questionnaires Among Active Duty Military Personnel With Posttraumatic Stress Disorder.

Zang Y, Gay NG, Kaczkurkin AN, McLean CP, Wachen JS, Yarvis JS, Litz BT, Yadin E, Mintz J, Roache JD, Young-McCaughan S, Peterson AL, Foa EB, Resick PA; STRONG STAR Consortium.

J Trauma Stress. 2018 Dec;31(6):826-836. doi: 10.1002/jts.22350. Epub 2018 Dec 12.

PMID:
30548330
11.

The Role of Social Support in Motivating Reductions in Alcohol Use: A Test of Three Models of Social Support in Alcohol-Impaired Drivers.

Moon TJ, Mathias CW, Mullen J, Karns-Wright TE, Hill-Kapturczak N, Roache JD, Dougherty DM.

Alcohol Clin Exp Res. 2019 Jan;43(1):123-134. doi: 10.1111/acer.13911. Epub 2018 Nov 15.

PMID:
30431660
12.

The pattern of symptom change during prolonged exposure therapy and present-centered therapy for PTSD in active duty military personnel.

Brown LA, Clapp JD, Kemp JJ, Yarvis JS, Dondanville KA, Litz BT, Mintz J, Roache JD, Young-McCaughan S, Peterson AL, Foa EB; STRONG STAR Consortium.

Psychol Med. 2019 Sep;49(12):1980-1989. doi: 10.1017/S0033291718002714. Epub 2018 Sep 17.

PMID:
30220261
13.

Processing transdermal alcohol concentration (TAC) data to detect low-level drinking.

Roache JD, Karns-Wright TE, Goros M, Hill-Kapturczak N, Mathias CW, Dougherty DM.

Alcohol. 2018 Sep 1. pii: S0741-8329(18)30110-1. doi: 10.1016/j.alcohol.2018.08.014. [Epub ahead of print]

PMID:
30179708
14.

Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans.

Back SE, Flanagan JC, Jones JL, Augur I, Peterson AL, Young-McCaughan S, Shirley DW, Henschel A, Joseph JE, Litz BT, Hancock AK, Roache JD, Mintz J, Wachen JS, Keane TM, Brady KT; Consortium to Alleviate PTSD.

Contemp Clin Trials. 2018 Oct;73:8-15. doi: 10.1016/j.cct.2018.08.009. Epub 2018 Aug 24.

15.

Design of a clinical effectiveness trial of in-home cognitive processing therapy for combat-related PTSD.

Peterson AL, Resick PA, Mintz J, Young-McCaughan S, McGeary DD, McGeary CA, Velligan DI, Macdonald A, Mata-Galan E, Holliday SL, Dillon KH, Roache JD, Williams Christians I, Moring JC, Bira LM, Nabity PS, Hancock AK, Hale WJ; STRONG STAR Consortium.

Contemp Clin Trials. 2018 Oct;73:27-35. doi: 10.1016/j.cct.2018.08.005. Epub 2018 Aug 23.

PMID:
30144629
16.

Pharmacokinetics of Phosphatidylethanol 16:0/20:4 in Human Blood After Alcohol Intake.

Lopez-Cruzan M, Roache JD, Hill-Kapturczak N, Karns-Wright TE, Dougherty DM, Sanchez JJ, Koek W, Javors MA.

Alcohol Clin Exp Res. 2018 Nov;42(11):2094-2099. doi: 10.1111/acer.13865. Epub 2018 Aug 26.

PMID:
30091144
17.

Intensive prolonged exposure therapy for combat-related posttraumatic stress disorder: Design and methodology of a randomized clinical trial.

Peterson AL, Foa EB, Blount TH, McLean CP, Shah DV, Young-McCaughan S, Litz BT, Schobitz RP, Castillo DT, Rentz TO, Yarvis JS, Dondanville KA, Fina BA, Hall-Clark BN, Brown LA, DeBeer BR, Jacoby VM, Hancock AK, Williamson DE, Evans WR, Synett S, Straud C, Hansen HR, Meyer EC, Javors MA, Sharrieff AM, Lara-Ruiz J, Koch LM, Roache JD, Mintz J, Keane TM; Consortium to Alleviate PTSD.

Contemp Clin Trials. 2018 Sep;72:126-136. doi: 10.1016/j.cct.2018.07.016. Epub 2018 Jul 25.

PMID:
30055335
18.

The correspondence between transdermal alcohol monitoring and daily self-reported alcohol consumption.

Karns-Wright TE, Dougherty DM, Hill-Kapturczak N, Mathias CW, Roache JD.

Addict Behav. 2018 Oct;85:147-152. doi: 10.1016/j.addbeh.2018.06.006. Epub 2018 Jun 11.

19.

Impact of cognitive behavioral therapy for insomnia disorder on sleep and comorbid symptoms in military personnel: a randomized clinical trial.

Taylor DJ, Peterson AL, Pruiksma KE, Hale WJ, Young-McCaughan S, Wilkerson A, Nicholson K, Litz BT, Dondanville KA, Roache JD, Borah EV, Brundige A, Mintz J; STRONG STAR Consortium.

Sleep. 2018 Jun 1;41(6). doi: 10.1093/sleep/zsy069.

PMID:
29618098
20.

Differences in the Synthesis and Elimination of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 After Acute Doses of Alcohol.

Hill-Kapturczak N, Dougherty DM, Roache JD, Karns-Wright TE, Javors MA.

Alcohol Clin Exp Res. 2018 May;42(5):851-860. doi: 10.1111/acer.13620. Epub 2018 Mar 30.

Supplemental Content

Loading ...
Support Center